Talking GLP-1 - America's Obsession to Stop an Urge
- Jonathan Poyer
- 21 hours ago
- 1 min read
GLP-1 therapies mimic a natural hormone that signals fullness, helping patients reduce calorie intake and achieve meaningful weight loss.
Discussion focused on the tradeoffs: while highly effective, reduced food intake can also mean lower protein consumption, increasing the risk of muscle loss—particularly in older adults.
The group also explored injectable vs. oral formulations, side effect profiles, and the expanding commercial landscape led by Novo Nordisk and Eli Lilly.
Bottom line: GLP-1s are reshaping obesity treatment, but long-term success depends on balancing weight loss with proper nutrition and muscle preservation.